Functional eye care is moving beyond the traditional clinic visit. Eye care providers, parents and distributors are looking for solutions that are clinically credible, practical for young patients and usable across hospitals, optometry centers and home therapy. Guangzhou Shijing Medical Software Co., Ltd. has spent more than fifteen years building a portfolio for this changing landscape.
Founded in 2008, Shijing Medical is a medical technology company focused on innovation in ophthalmology and optometry. The company invests in artificial intelligence (AI), image analysis and virtual reality (VR), with a mission to become a leader in full-lifecycle functional eye disease solutions. Its work combines digital technology with clinical insight to support how functional eye conditions are diagnosed, trained and managed.
Two Core Solutions for Functional Eye Care
Shijing Medical's portfolio is built around two digital diagnosis and treatment solutions: DOBOSO, a visual function training solution, and BaBy Blissful, a photobiomodulation (PBM) solution. Together, they address different needs within functional eye care and give partners a broader base for portfolio development.
DOBOSO brings visual function training into a digital, VR-enabled environment. It is designed for use in eye hospitals and optometry centers, and it offers distributors a digital vision therapy option that aligns with growing interest in VR-assisted care and home-based training.
BaBy Blissful applies PBM photobiomodulation in a digital diagnosis and treatment solution. It expands the portfolio beyond visual training and gives eye care professionals and partners a complementary approach for functional eye care. As with DOBOSO, the solution reflects Shijing Medical's focus on combining digital tools with practical clinical application.
Proven Across Hospitals, Optometry Centers and Homes
Shijing Medical's products are used in more than 3,000 eye hospitals and optometry centers across China, as well as in home therapy settings. Cumulative use has exceeded 500,000 people, and the company reports positive feedback from clinicians and patients' parents. In its product category, Shijing Medical states that its market share has remained a leading position in the industry.
This real-world footprint matters for overseas buyers. It shows that the solutions are not limited to a single care setting. They are used in professional environments and in home therapy, which gives distributors a way to discuss care that extends beyond a single appointment. The portfolio is also relevant to pediatric myopia management, amblyopia and strabismus digital treatment, and broader visual function training.
Research, Standards and Industry Recognition
Shijing Medical supports its products with a substantial research and intellectual property base. The company has laid out more than 200 intellectual property assets, including more than 60 authorized invention patents. It has received provincial key research and development project approvals and has carried out clinical trials and research collaborations with a number of well-known medical institutions in China.
The company has also led or participated in the development of team and industry standards, including the 'VR Visual Training System Technical and Application Specification.' In addition, Shijing Medical has jointly released important industry reports with Frost & Sullivan and MedSci, including the '2026 Blue Book on the Current Status and Future Trends of Myopia Management in Children and Adolescents,' the 'Blue Book on the Current Status of Digital Treatment for Amblyopia and Strabismus in Chinese Children' and the 'White Paper on the Current Status of Digital Treatment for Amblyopia and Strabismus in Chinese Children.'
These activities have earned the company recognition including placement on the 'Guangzhou Proposed Listed High-Tech Enterprise Reserve Top 100' list, selection as a 'Deloitte China Rising Star,' and awards such as 'China Digital Therapeutics Top 10,' the 'Global Ophthalmology Clinical Application Award' and 'China Visual Function Training Leading Brand.'
Why the Global Market Is Watching Digital Eye Care
Eye care systems around the world are looking for ways to reach more patients, support earlier intervention and make functional eye care more engaging. Digital therapeutics, VR-assisted training and PBM photobiomodulation are part of that shift. For distributors, the opportunity is to work with a partner that combines product depth with clinical experience, industry standards and a track record in a large and demanding eye care market.
Shijing Medical's focus on functional eye disease across the full lifecycle is especially relevant for partners building a portfolio in pediatric eye care, myopia management, amblyopia and strabismus. The company's experience in China's eye hospital and optometry center network can help overseas partners evaluate how digital solutions might fit their own markets.
Partner with Shijing Medical
Shijing Medical welcomes overseas buyers, distributors and clinical partners who share its commitment to functional eye care. Whether you are expanding a digital vision therapy portfolio, exploring PBM photobiomodulation solutions or looking for a long-term partner with deep experience in ophthalmology and optometry, the team is ready to discuss how we can work together.
Contact Shijing Medical:
Website: www.shijingmed.com
Phone: +86 4008777511 / +86 15021168718
WeChat: yesmylord123
Email: fangtao@topeye.cn

